Copyright
©2005 Baishideng Publishing Group Inc. All rights reserved.
World J Gastroenterol. Jan 28, 2005; 11(4): 612-613
Published online Jan 28, 2005. doi: 10.3748/wjg.v11.i4.612
Published online Jan 28, 2005. doi: 10.3748/wjg.v11.i4.612
Radiofrequency ablation of recurrent cholangiocarcinoma after orthotopic liver transplantation - a case report
Rakesh Rai, Derek Manas, HPB Surgery and Liver Transplant Unit, Freeman Hospital, Newcastle, UK
John Rose, Department of Interventional Radiology, Freeman Hospital, Newcastle, UK
Author contributions: All authors contributed equally to the work.
Correspondence to: Mr. Rakesh Rai, 52 Barrs Court Road, Hereford, HR1 1EQ, UK. rai2000@hotmail.com
Telephone: +44-1432-266039
Received: December 19, 2003
Revised: December 22, 2003
Accepted: May 25, 2004
Published online: January 28, 2005
Revised: December 22, 2003
Accepted: May 25, 2004
Published online: January 28, 2005
Abstract
AIM: To report the use of radiofrequency ablation in the treatment of recurrent cholangiocarcinoma in the transplanted liver.
METHODS: A lady who underwent orthotopic liver transplantation (OLT) for intrahepatic cholangiocarcinoma recurrence of tumour 13 mo after transplantation inspite of adjuvant chemotherapy. Her recurrent tumour was treated with radiofrequency ablation.
RESULTS: She survived for 18 mo following the recurrence of her tumour.
CONCLUSION: Radiofrequency ablation can be used safely in the transplanted liver to treat recurrent tumour.